Cargando…

Prevalence, awareness, treatment, and risk factor control of high atherosclerotic cardiovascular disease risk in Guangzhou, China

BACKGROUND: Identifying individuals at high risk of atherosclerotic cardiovascular disease (ASCVD) and implementing targeted prevention strategies might be the key to reducing the heavy disease burden in China. This study aimed to evaluate the prevalence, awareness, treatment, and risk factor contro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hui, Lin, Weiquan, Tu, Kexin, Zhou, Qin, Wang, Chang, Sun, Minying, Li, Yaohui, Liu, Xiangyi, Lin, Guozhen, Li, Sidong, Bao, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379630/ https://www.ncbi.nlm.nih.gov/pubmed/37522083 http://dx.doi.org/10.3389/fcvm.2023.1092058

Ejemplares similares

Prevalence of Noncommunicable Diseases and Their Risk Factors in Guangzhou, China
por: Pan, Bingying, et al.
Publicado: (2014)

Atherosclerotic Cardiovascular Disease Risk and Lipid-Lowering Therapy Requirement in China
por: Bi, Lei, et al.
Publicado: (2022)

Glycemia and Atherosclerotic Cardiovascular Disease: Exploring the Gap Between Risk Marker and Risk Factor
por: Nahmias, Avital, et al.
Publicado: (2020)

Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment
por: Wang, Kexin, et al.
Publicado: (2022)

Common variable immunodeficiency—an independent risk factor for atherosclerotic cardiovascular diseases
por: Mattila, Juho, et al.
Publicado: (2023)

Coronary Atherosclerotic Disease and Cancer: Risk Factors and Interrelation
por: Li, Jinjing, et al.
Publicado: (2022)

Metabolomics profile and 10-year atherosclerotic cardiovascular disease (ASCVD) risk score
por: Dehghanbanadaki, Hojat, et al.
Publicado: (2023)

Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview
por: Wu, Min, et al.
Publicado: (2021)

Socioeconomic status and modification of atherosclerotic cardiovascular disease risk prediction: epidemiological analysis using data from the atherosclerosis risk in communities study
por: Henderson, Kamal, et al.
Publicado: (2022)

Atherosclerotic cardiovascular disease risk stratification and management in type 2 diabetes: review of recent evidence-based guidelines
por: Gourdy, Pierre, et al.
Publicado: (2023)

Predictive value of 10-year atherosclerotic cardiovascular disease risk equations from the China-PAR for new-onset lower extremity peripheral artery disease
por: He, Pengkang, et al.
Publicado: (2022)

The effect of telemedicine on secondary prevention of atherosclerotic cardiovascular disease: A systematic review and meta-analysis
por: Deng, Liangying, et al.
Publicado: (2022)

The relationship between Type D personality with atherosclerotic plaque and cardiovascular events: The mediation effect of inflammation and kynurenine/tryptophan metabolism
por: Wang, Yini, et al.
Publicado: (2022)

The Spectrum of B Cell Functions in Atherosclerotic Cardiovascular Disease
por: Smeets, Diede, et al.
Publicado: (2022)

Healthy Lifestyle Score and Glycemic Control in Type 2 Diabetes Mellitus Patients: A City-Wide Survey in China
por: Che, Mengmeng, et al.
Publicado: (2023)

Interaction analysis of the new pooled cohort equations for 10-year atherosclerotic cardiovascular disease risk estimation: a simulation analysis
por: Schiros, Chun G, et al.
Publicado: (2015)

Cumulative non-high-density lipoprotein cholesterol burden and risk of atherosclerotic cardiovascular disease: a prospective community-based study
por: Guan, Xu-Min, et al.
Publicado: (2023)

Molecular Imaging and Non-molecular Imaging of Atherosclerotic Plaque Thrombosis
por: Guo, Bingchen, et al.
Publicado: (2021)

Effect of PCSK9 on atherosclerotic cardiovascular diseases and its mechanisms: Focus on immune regulation
por: Ma, Minglu, et al.
Publicado: (2023)

Association Between Periodontal Disease and Atherosclerotic Cardiovascular Diseases: Revisited
por: Zardawi, Faraedon, et al.
Publicado: (2021)

Atherosclerotic cardiovascular diseases in inflammatory bowel diseases: to the heart of the issue
por: Gabbiadini, Roberto, et al.
Publicado: (2023)

Higher risk of future events, mortality and greater healthcare use among patients with increasingly recurrent atherosclerotic cardiovascular disease events in Taiwan: a retrospective cohort study
por: Hsu, Chia-Yun, et al.
Publicado: (2023)

Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease
por: Aday, Aaron W., et al.
Publicado: (2019)

Atherosclerotic Cardiovascular Risk in Japan
por: Nojiri, Shuko, et al.
Publicado: (2017)

Higher risk of cardiovascular mortality than cancer mortality among long-term cancer survivors
por: Wang, Zhipeng, et al.
Publicado: (2023)

The role of glucocorticoids in increasing cardiovascular risk
por: Deng, Hai-Wei, et al.
Publicado: (2023)

Aortic arch calcification and risk of all-cause mortality and cardiovascular disease: The Guangzhou Biobank Cohort Study
por: Tian, Wen Bo, et al.
Publicado: (2022)

E3 Ubiquitin Ligases as Immunotherapeutic Target in Atherosclerotic Cardiovascular Disease
por: Poels, Kikkie, et al.
Publicado: (2020)

The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
por: Finney, Alexandra C., et al.
Publicado: (2023)

Trends in the prevalence of elevated cardiovascular risk and the control of its risk factors Among US adults, 2001–2020
por: Huang, Haitao, et al.
Publicado: (2023)

Negative Risk Markers for Cardiovascular Risk Evaluation in Chinese Adults
por: Bie, Lizhan, et al.
Publicado: (2022)

Efficacy and safety of hybutimibe in combination with atorvastatin for treatment of hypercholesteremia among patients with atherosclerotic cardiovascular disease risk equivalent: A multicenter, randomized, double-blinded phase III study
por: Qi, Litong, et al.
Publicado: (2022)

Risk stratification of atherosclerotic cardiovascular disease in Chinese adults
por: Yang, Xue-Li, et al.
Publicado: (2016)

Achievement of low-density lipoprotein cholesterol targets in Chinese patients with atherosclerotic cardiovascular disease after receiving statins and ezetimibe
por: Cheng, Yinchu, et al.
Publicado: (2022)

Underutilisation of cardiovascular medications among at-risk individuals
por: Lewis, S J, et al.
Publicado: (2010)

Association between spicy foods consumption and cardiovascular disease risk factors: Guangzhou Biobank Cohort Study
por: Zhang, Yu, et al.
Publicado: (2022)

Plasma Oxylipins: A Potential Risk Assessment Tool in Atherosclerotic Coronary Artery Disease
por: Le, D. Elizabeth, et al.
Publicado: (2021)

Association between visceral obesity and 10-year risk of first atherosclerotic cardiovascular diseases events among American adults: National Health and Nutrition Examination Survey
por: Zheng, Liying, et al.
Publicado: (2023)

Mass screening for colorectal cancer in a population of two million older adults in Guangzhou, China
por: Lin, Guozhen, et al.
Publicado: (2019)

Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism
por: Lin, Xiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a84ef0hpfn6op7nnsc6b8jhnm1